Our pioneering SomaScan® Assay is a game changer for your oncology research

The SomaScan Assay is designed for sensitivity and specificity to detect low-abundant proteins, such as cytokines, to lead to your next breakthrough discovery.

The SomaScan® Assay empowers discovery

Accelerate your biomarker discovery with sensitive detection of 7,000 proteins from a 55-μL sample.


Identify unique cancer-specific protein biomarkers for future diagnostic indicators.


Monitor proteins over time for markers indicative of disease progression/regression.


Reveal proteins that correlate with a cancer event for development of preventive measures.


Define protein signatures that correlate with specific subtypes for use in therapeutic development.

Also available: SomaScan® panels for targeted data


168 analytes


863 analytes

Download our tech note for the SomaScan® Assay

Download Tech Note

Additional resources

See relevant publications in our interactive viewer

Review publications